| Long‐term outcome in localized extranodal mucosa‐associated lymphoid tissue lymphomas treated with radiotherapy JS Goda, M Gospodarowicz, M Pintilie, W Wells, DC Hodgson, A Sun, ... Cancer 116 (16), 3815-3824, 2010 | 243 | 2010 |
| Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the International Lymphoma Radiation Oncology Group RW Tsang, BA Campbell, JS Goda, CR Kelsey, YM Kirova, RR Parikh, ... International Journal of Radiation Oncology* Biology* Physics 101 (4), 794-808, 2018 | 163 | 2018 |
| Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity JS Goda, LW Le, NJ Lapperriere, BA Millar, D Payne, MK Gospodarowicz, ... International Journal of Radiation Oncology* Biology* Physics 81 (4), e659-e666, 2011 | 120 | 2011 |
| Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. IT Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B ... Int J Radiat Oncol Biol Phys. 100 (3), 652-669, 2018 | 84 | 2018 |
| Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence E Kaur, J Rajendra, S Jadhav, E Shridhar, JS Goda, A Moiyadi, S Dutt Carcinogenesis 36 (6), 685-695, 2015 | 76 | 2015 |
| Efficacy of stereotactic conformal radiotherapy vs conventional radiotherapy on benign and low-grade brain tumors: a randomized clinical trial R Jalali, T Gupta, JS Goda, S Goswami, N Shah, D Dutta, U Krishna, ... JAMA oncology 3 (10), 1368-1376, 2017 | 70 | 2017 |
| Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 … A Dasgupta, T Gupta, S Pungavkar, N Shirsat, S Epari, G Chinnaswamy, ... Neuro-oncology 21 (1), 115-124, 2019 | 62 | 2019 |
| High‐risk extracranial chondrosarcoma: Long‐term results of surgery and radiation therapy JS Goda, PC Ferguson, B O'Sullivan, CN Catton, AM Griffin, JS Wunder, ... Cancer 117 (11), 2513-2519, 2011 | 54 | 2011 |
| A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin S Prabhu, JS Goda, S Mutalik, BS Mohanty, P Chaudhari, S Rai, N Udupa, ... Nanoscale 9 (30), 10919-10932, 2017 | 51 | 2017 |
| Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors JS Goda, D Dutta, U Krishna, S Goswami, V Kothavade, S Kannan, ... Neuro-oncology 22 (11), 1677-1685, 2020 | 47 | 2020 |
| Role of salvage radiation therapy for patients with relapsed or refractory Hodgkin lymphoma who failed autologous stem cell transplant JS Goda, C Massey, J Kuruvilla, MK Gospodarowicz, W Wells, ... International Journal of Radiation Oncology* Biology* Physics 84 (3), e329-e335, 2012 | 43 | 2012 |
| Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping T Gupta, M Maitre, GJ Sastri, R Krishnatry, N Shirsat, S Epari, A Sahay, ... Journal of Neuro-Oncology 144, 283-291, 2019 | 37 | 2019 |
| Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer J Thoms, JS Goda, AR Zlotta, NE Fleshner, TH Van Der Kwast, S Supiot, ... Nature reviews Clinical oncology 8 (2), 107-113, 2011 | 37 | 2011 |
| Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck—a phase III trial from a single institution in India S Ghoshal, JS Goda, I Mallick, TS Kehwar, SC Sharma Clinical Oncology 20 (3), 212-220, 2008 | 36 | 2008 |
| Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches MM Hegde, S Prabhu, S Mutalik, A Chatterjee, JS Goda, BS Satish Rao Journal of Pharmaceutical Investigation, 1-26, 2022 | 28 | 2022 |
| Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study JS Goda, D Dutta, N Raut, SL Juvekar, N Purandare, V Rangarajan, ... Pediatric Neurosurgery 49 (5), 274-281, 2014 | 28 | 2014 |
| Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma. JR Tonse R, Gupta T, Epari S, Shastri JG, Gurav M, Bano N J Neurooncol, 2017 | 27* | 2017 |
| Tumor radiomic features complement clinico-radiological factors in predicting long-term local control and laryngectomy free survival in locally advanced laryngo-pharyngeal cancers JP Agarwal, S Sinha, JS Goda, K Joshi, R Mhatre, S Kannan, SG Laskar, ... The British Journal of Radiology 93 (1109), 20190857, 2020 | 25 | 2020 |
| Oral administration of 3, 3′-diselenodipropionic acid prevents thoracic radiation induced pneumonitis in mice by suppressing NF-kB/IL-17/G-CSF/neutrophil axis KA Gandhi, JS Goda, VV Gandhi, A Sadanpurwala, VK Jain, K Joshi, ... Free Radical Biology and Medicine 145, 8-19, 2019 | 24 | 2019 |
| Steroid receptors, HER2/neu and Ki-67, in endometrioid type of endometrial carcinoma: Correlation with conventional histomorphological features of prognosis D Chakravarty, N Gupta, JS Goda, R Srinivasan, FD Patel, L Dhaliwal Acta histochemica 112 (4), 355-363, 2010 | 21 | 2010 |
Rakesh Jalali, MD, FRCP(Edin)Director, Apollo Proton Cancer Centre, Chennai. Formerly Professor Radiation Oncology, TMH MumbaiVerified email at apollohospitals.com
